Join
Live feed
·
PRReleasevia Quantisnow
InspireMD Inc. logo

InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System

ByQuantisnow·Wall Street's wire, on your screen.
NSPR· InspireMD Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NSPR (InspireMD Inc.) and more on Quantisnow.